Question-and-Answer Session
Operator
Thank you. (Operator Instructions) Mr. Snyder, our first question comes from Pamela Bassett of Cantor Fitzgerald. Please proceed.
Pamela Bassett - Cantor Fitzgerald
Hi, thanks for taking my call. Can you hear me okay?
Kent Snyder
Hi, Pamela.
Pamela Bassett - Cantor Fitzgerald
Hi. Congratulations on all the progress. I wonder if you can tell us a little bit more about how the launch will take place with Firmenich on the sucralose enhancers. Do you think it will be a system that they are introducing, or the sucralose enhancer on its own? Should we be thinking about revenue towards the end of the year from this or that will come in 2010? Thank you.
Kent Snyder
Pamela, we are limited, due to confidentiality obligations, not to say too much about the plans with Firmenich, but in working with them and I can ask Sharon to comment further. We are pleased with their activities today, both in terms of looking at production scale up and product development work. We are aware that they are out talking to leading food and beverage companies and then speaking with them. It's our anticipation that the launch would occur in the fourth quarter of 2009.
We really can’t say, at this point in time, how they will be rolling out S2383 and what type of system it will be incorporated in. I think that’s something that really Firmenich would have to comment on themselves, but we are confident and we like the progress that we see in terms of them moving 2383 through the initial product development process. John, do you have any further comments on . . .?
John Poyhonen
Yes, I just want to additional comment. Hi, Pamela.
Pamela Bassett - Cantor Fitzgerald
Hi.
John Poyhonen
With respect to when we expect to recognize revenue, as you recall, our royalty revenues recognized one quarter in arrears, so with the anticipated first launch in the fourth quarter of 2009, we wouldn’t expect to recognize any revenue from this program until the first quarter of 2010.
Kent Snyder
Any other further comment?
Sharon Wicker
We are in close communication with Firmenich, and I will just underscore again, as Kent did in description, that we are extremely pleased with the progress that they've made and the urgency that they are demonstrating and are moving through their pre-commercialization activity.
Pamela Bassett - Cantor Fitzgerald
Okay. Great. Thanks very much. Congratulations on all the progress. If I can leave you with one other question about the bitter programming, and there are two, just to be clear, the bitter program with Solae, and then there is a bitter program where you have two other alliances or partners. Might you be adding partners in the bitter area, say from pharma and OTC companies?
- To read the full transcript on Seeking Alpha, click here »
